Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS)’s share price gapped up prior to trading on Thursday after an insider bought additional shares in the company. The stock had previously closed at $1.51, but opened at $1.56. Corindus Vascular Robotics shares last traded at $1.76, with a volume of 2882165 shares.

Specifically, major shareholder Hudson Executive Capital Lp acquired 2,899,391 shares of Corindus Vascular Robotics stock in a transaction on Tuesday, March 12th. The stock was purchased at an average cost of $1.38 per share, with a total value of $4,001,159.58. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Louis A. Cannon acquired 573,798 shares of Corindus Vascular Robotics stock in a transaction on Tuesday, March 12th. The shares were bought at an average cost of $1.38 per share, with a total value of $791,841.24. The disclosure for this purchase can be found here.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last issued its earnings results on Tuesday, March 12th. The medical equipment provider reported ($0.04) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.04). The business had revenue of $4.67 million for the quarter, compared to analysts’ expectations of $5.60 million.

Hedge funds have recently modified their holdings of the company. Jane Street Group LLC acquired a new stake in shares of Corindus Vascular Robotics in the 4th quarter worth approximately $36,000. HRT Financial LLC acquired a new stake in shares of Corindus Vascular Robotics in the 4th quarter worth approximately $44,000. Virtu Financial LLC acquired a new stake in shares of Corindus Vascular Robotics in the 4th quarter worth approximately $64,000. Citadel Advisors LLC grew its holdings in shares of Corindus Vascular Robotics by 205.4% in the 3rd quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock worth $164,000 after acquiring an additional 77,829 shares during the period. Finally, Barclays PLC acquired a new stake in shares of Corindus Vascular Robotics in the 4th quarter worth approximately $325,000.

COPYRIGHT VIOLATION NOTICE: “Corindus Vascular Robotics (CVRS) Shares Gap Up Following Insider Buying Activity” was first posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/corindus-vascular-robotics-cvrs-shares-gap-up-following-insider-buying-activity/2890967.html.

About Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.

Featured Story: Is it better to buy a fund with a higher or lower NAV?

Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.